In Journal of viral hepatitis ; h5-index 45.0
Accurate liver necroinflammatory activity diagnosis could guide the clinical decision-making in chronic hepatitis B (CHB) patients.This study aimed to build a non-invasive diagnostic model for liver necroinflammatory activity by incorporating deep learning features and clinico-biochemical characteristics in CHB patients. A total of 239 CHB patients who underwent liver biopsy were recruited and randomly divided into a training cohort (n = 179) and an independent validation cohort (n = 60). Bidirectional stepwise selection identified independent clinico-biochemical characteristics. Multivariate logistic regression analysis was used to establish the final combined model by incorporating clinico-biochemical and deep learning features. Predictive performance was evaluated by discrimination and clinical usefulness. Immunoglobulin M, platelets, laminin, type IV collagen, gamma-glutamyl transferase, alanine aminotransferase, aspartate transaminase, alkaline phosphatase, direct bilirubin, and total bilirubin were identified as independent factors. The combined model exhibited better performance than models based on clinico-biochemical characteristics alone, with an AUC of 0.942 (95% confidence interval [CI], 0.912-0.969) for necroinflammatory activity ≥G2 and 0.885 (95% CI, 0.829-0.934) for ≥G3 in the training cohort, and 0.938 (95% CI, 0.867-0.993) and 0.854 (95% CI, 0.764-0.934) in the validation cohort, respectively. The decision curve confirmed its clinical usefulness. The combined model provided an accurate non-invasive prediction of liver necroinflammatory activity, which might contribute to clinical decision-making in CHB patients.
Zhang Shuaitong, Chen Zhiyuan, Wei Jingwei, Chi Xiaoling, Zhou Dongjing, Ouyang Shuman, Peng Jing, Xiao Huanming, Tian Jie, Liu Yupin
Chronic hepatitis B, Deep learning, Liver disease, Machine learning, Necroinflammatory activity